CIDER
@cideruga.bsky.social
Center for Influenza Disease and Emergence Research
Reposted by CIDER
Why do some people get seriously ill while others don't? Our new study in @pnas.org investigated how a population of memory T cells influence #COVID severity
Read the paper: go.unimelb.edu.au/4zkp
Or our article here: go.unimelb.edu.au/2zkp
@katherinekedz.bsky.social @thedohertyinst.bsky.social
Read the paper: go.unimelb.edu.au/4zkp
Or our article here: go.unimelb.edu.au/2zkp
@katherinekedz.bsky.social @thedohertyinst.bsky.social
HLA-B*15:01-positive severe COVID-19 patients lack CD8+ T cell pools with highly expanded public clonotypes | PNAS
Understanding host factors driving asymptomatic versus severe disease outcomes is
of key importance if we are to control emerging and re-emerging v...
go.unimelb.edu.au
September 5, 2025 at 8:14 AM
Why do some people get seriously ill while others don't? Our new study in @pnas.org investigated how a population of memory T cells influence #COVID severity
Read the paper: go.unimelb.edu.au/4zkp
Or our article here: go.unimelb.edu.au/2zkp
@katherinekedz.bsky.social @thedohertyinst.bsky.social
Read the paper: go.unimelb.edu.au/4zkp
Or our article here: go.unimelb.edu.au/2zkp
@katherinekedz.bsky.social @thedohertyinst.bsky.social
CIDER hosted the 4th UGA Flu Meeting 🦠 bringing together scientists, trainees, & collaborators 👩🏾🔬👨🏼🔬👩🏻🔬 across campus. A huge thank you to all who presented, asked questions, & shared ideas. These types of gatherings remind us that advancing science is truly a team effort! @ugaresearch.bsky.social
September 9, 2025 at 11:52 AM
CIDER hosted the 4th UGA Flu Meeting 🦠 bringing together scientists, trainees, & collaborators 👩🏾🔬👨🏼🔬👩🏻🔬 across campus. A huge thank you to all who presented, asked questions, & shared ideas. These types of gatherings remind us that advancing science is truly a team effort! @ugaresearch.bsky.social
Great job to the team on this recent publication👏 "Evaluating the Breadth and Reliability of Influenza Vaccine Protection Indicators: a Secondary Analysis of an Animal Challenge Trial" @andreashandel.bsky.social @ceirrnetwork.bsky.social #Influenza #PublicHealth #Virology
Evaluating the Breadth and Reliability of Influenza Vaccine Protection Indicators: a Secondary Analysis of an Animal Challenge Trial
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Evaluating the Breadth and Reliability of Influenza Vaccine Protection Indicators: a Secondary Analysis of an Animal Challenge Trial
Hemagglutination inhibition (HAI) titers are key correlates of influenza vaccine protection, yet a systematic comparison of HAI-based immunogenicity indicators is lacking for guiding vaccine development.
academic.oup.com
July 23, 2025 at 12:59 PM
Great job to the team on this recent publication👏 "Evaluating the Breadth and Reliability of Influenza Vaccine Protection Indicators: a Secondary Analysis of an Animal Challenge Trial" @andreashandel.bsky.social @ceirrnetwork.bsky.social #Influenza #PublicHealth #Virology
Congratulations to the team on their recent publication in JAVMA: “Controlling bird flu is urgent—for dairy, wildlife, poultry, pets, and people.” 🚨 @smtflu.bsky.social
@ceirrnetwork.bsky.social avmajournals.avma.org/view/journal...
@ceirrnetwork.bsky.social avmajournals.avma.org/view/journal...
July 18, 2025 at 11:10 AM
Congratulations to the team on their recent publication in JAVMA: “Controlling bird flu is urgent—for dairy, wildlife, poultry, pets, and people.” 🚨 @smtflu.bsky.social
@ceirrnetwork.bsky.social avmajournals.avma.org/view/journal...
@ceirrnetwork.bsky.social avmajournals.avma.org/view/journal...
It's a pleasure to introduce Dr. Mark Tompkins 2025 lab at
@ugaresearch.bsky.social! 🧬🦠Their groundbreaking work in virology and influenza research is truly impressive. If you're looking to collaborate on innovative science, this is the team to connect with! 🔬🤝 @ceirrnetwork.bsky.social
@ugaresearch.bsky.social! 🧬🦠Their groundbreaking work in virology and influenza research is truly impressive. If you're looking to collaborate on innovative science, this is the team to connect with! 🔬🤝 @ceirrnetwork.bsky.social
July 16, 2025 at 11:19 AM
It's a pleasure to introduce Dr. Mark Tompkins 2025 lab at
@ugaresearch.bsky.social! 🧬🦠Their groundbreaking work in virology and influenza research is truly impressive. If you're looking to collaborate on innovative science, this is the team to connect with! 🔬🤝 @ceirrnetwork.bsky.social
@ugaresearch.bsky.social! 🧬🦠Their groundbreaking work in virology and influenza research is truly impressive. If you're looking to collaborate on innovative science, this is the team to connect with! 🔬🤝 @ceirrnetwork.bsky.social
🎉 Congratulations to our team on the latest publication! 📄 Check it out here: pubmed.ncbi.nlm.nih.gov/40563242/
Proud of the work and impact we're making. #Research #PublicHealth #ScienceCheck @ceirrnetwork.bsky.social
Proud of the work and impact we're making. #Research #PublicHealth #ScienceCheck @ceirrnetwork.bsky.social
June 26, 2025 at 6:33 PM
🎉 Congratulations to our team on the latest publication! 📄 Check it out here: pubmed.ncbi.nlm.nih.gov/40563242/
Proud of the work and impact we're making. #Research #PublicHealth #ScienceCheck @ceirrnetwork.bsky.social
Proud of the work and impact we're making. #Research #PublicHealth #ScienceCheck @ceirrnetwork.bsky.social
🎉 Congratulations on your recent publication! 📝📚 Such an amazing accomplishment by Leke Lyu @gabriella-veytsel.bsky.social @guppy-stott.bsky.social and colleagues. Check it out ⬇️ So proud of you! 🙌📚 @ceirrnetwork.bsky.social
Characterizing spatial epidemiology in a heterogeneous transmission landscape using the spatial transmission count statistic PubMed
Characterizing spatial epidemiology in a heterogeneous transmission landscape using the spatial transmission count statistic
CONCLUSIONS: In this study, we introduce the Source Sink Score, which determines whether a localized outbreak serves as a source or sink for other regions, and the Local Import Score, which assesses whether the outbreak has transitioned to local transmission rather than being maintained by continued introductions. These epidemiological statistics provide actionable insights for developing public health interventions tailored to the needs of affected areas.
dlvr.it
June 3, 2025 at 11:58 AM
🎉 Congratulations on your recent publication! 📝📚 Such an amazing accomplishment by Leke Lyu @gabriella-veytsel.bsky.social @guppy-stott.bsky.social and colleagues. Check it out ⬇️ So proud of you! 🙌📚 @ceirrnetwork.bsky.social
Congratulations to the research team on their recent publication in Nature, titled "Receptor-binding specificity of a bovine influenza A virus" 💯🦠🐮 @smtflu.bsky.social
#InfluenzaResearch #CollaborativeScience @ugaresearch.bsky.social www.nature.com/articles/s41...
#InfluenzaResearch #CollaborativeScience @ugaresearch.bsky.social www.nature.com/articles/s41...
Receptor-binding specificity of a bovine influenza A virus - Nature
Nature - Receptor-binding specificity of a bovine influenza A virus
www.nature.com
April 16, 2025 at 6:24 PM
Congratulations to the research team on their recent publication in Nature, titled "Receptor-binding specificity of a bovine influenza A virus" 💯🦠🐮 @smtflu.bsky.social
#InfluenzaResearch #CollaborativeScience @ugaresearch.bsky.social www.nature.com/articles/s41...
#InfluenzaResearch #CollaborativeScience @ugaresearch.bsky.social www.nature.com/articles/s41...
Shoutout to the best boss ever for treating us to an unforgettable night with the Athens Rock Lobsters! 🎸🦞What a vibe, what a leader! 🙌 #Gratitude #TeamGoals #BestBoss @smtflu.bsky.social Thank you Dr. Tompkins!
April 2, 2025 at 12:59 AM
Shoutout to the best boss ever for treating us to an unforgettable night with the Athens Rock Lobsters! 🎸🦞What a vibe, what a leader! 🙌 #Gratitude #TeamGoals #BestBoss @smtflu.bsky.social Thank you Dr. Tompkins!
Wrapped up another incredible UGA Flu Meeting!🧬🔬 Scientists came together to share insights, strategize research, and push the boundaries of flu prevention. Let’s keep the momentum going—because science never stops, and neither do we! 💪#UGAScience @smtflu.bsky.social @andreashandel.bsky.social
February 21, 2025 at 4:41 PM
Wrapped up another incredible UGA Flu Meeting!🧬🔬 Scientists came together to share insights, strategize research, and push the boundaries of flu prevention. Let’s keep the momentum going—because science never stops, and neither do we! 💪#UGAScience @smtflu.bsky.social @andreashandel.bsky.social
Reposted by CIDER
Are we serologically prepared against an avian influenza pandemic and could seasonal flu vaccines help us? https://www.biorxiv.org/content/10.1101/2024.11.06.622244v1
Are we serologically prepared against an avian influenza pandemic and could seasonal flu vaccines help us? https://www.biorxiv.org/content/10.1101/2024.11.06.622244v1
The current situation with H5N1 highly pathogenic avian influenza virus (HPAI) is causing a worldwid
www.biorxiv.org
November 8, 2024 at 10:17 PM
Are we serologically prepared against an avian influenza pandemic and could seasonal flu vaccines help us? https://www.biorxiv.org/content/10.1101/2024.11.06.622244v1
Reposted by CIDER
The Center for Vaccines and Immunology at the University of Georgia is recruiting an Asst or Assoc Professor Immunologist! Details on the position and how to apply can be found here: www.ugajobsearch.com/postings/409.... You can learn more about UGA and Athens here: hr.uga.edu/Prospective_...
Assistant or Associate Professor of CVI
The Center for Vaccines and Immunology in the College of Veterinary Medicine at the University of Georgia seeks an outstanding researcher in immunology for a tenure-track Assistant or Associate Profes...
www.ugajobsearch.com
January 2, 2025 at 12:32 PM
The Center for Vaccines and Immunology at the University of Georgia is recruiting an Asst or Assoc Professor Immunologist! Details on the position and how to apply can be found here: www.ugajobsearch.com/postings/409.... You can learn more about UGA and Athens here: hr.uga.edu/Prospective_...
Reposted by CIDER
Want to learn about the treatment of RVI in immunocompromised patients?
Join us for the next @ESCMID.bsky.social ESGICH/ESGREV webinar on the treatment of RVI.
Chairs: Hans Hirsch and @michaelisonmd.bsky.social
Talks by: Pauline Vetter, Jose Luise Pinana, Fareed Khawaja
Join us for the next @ESCMID.bsky.social ESGICH/ESGREV webinar on the treatment of RVI.
Chairs: Hans Hirsch and @michaelisonmd.bsky.social
Talks by: Pauline Vetter, Jose Luise Pinana, Fareed Khawaja
November 18, 2024 at 1:49 PM
Want to learn about the treatment of RVI in immunocompromised patients?
Join us for the next @ESCMID.bsky.social ESGICH/ESGREV webinar on the treatment of RVI.
Chairs: Hans Hirsch and @michaelisonmd.bsky.social
Talks by: Pauline Vetter, Jose Luise Pinana, Fareed Khawaja
Join us for the next @ESCMID.bsky.social ESGICH/ESGREV webinar on the treatment of RVI.
Chairs: Hans Hirsch and @michaelisonmd.bsky.social
Talks by: Pauline Vetter, Jose Luise Pinana, Fareed Khawaja